
Vetter confirms new managing director
pharmafile | April 15, 2015 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Oliver Albrecht, Vetter
German contract development and manufacturing organisation Vetter has appointed Oliver Albrecht as a managing director.
Albrecht replaces Max Horn in the position who left the company in June last year, and has more than 20 years of experience managing international, medium-sized listed companies both as a managing director and as chief financial officer in industries including banking, automotive, and mechanical engineering.
In recent years Albrecht held the position of chief financial officer for SHW AG headquartered in Aalen, Germany and acted also as an independent consultant for mid-sized companies.
His previous positions include senior posts at companies including CFO for centrotherm photovoltaics, and as a director in the financial and banking sector.
Peter Soelkner and Thomas Otto, Vetter’s two managing directors, added: We are happy to have this managing director position filled with someone having the background that Oliver Albrecht offers. We are pleased to assist our new colleague in any way possible to make his start at Vetter both promising and productive. We wish him success in his new position.”
Related Content
Vetter swells filling capacity with $100m investment
German contract development and manufacturing organisation (CDMO) Vetter says it is planning to invest over …
Pharma manufacturing news in brief
Excipients trade body IPEC will set up a branch in India next month, plus updates …






